Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseJ. Clin. Oncol 2021 Jul 26;[EPub Ahead of Print], M Bolla, A Neven, P Maingon, C Carrie, A Boladeras, D Andreopoulos, A Engelen, S Sundar, EM van der Steen-Banasik, J Armstrong, K Peignaux-Casasnovas, J Boustani, FG Herrera, BR Pieters, A Slot, A Bahl, CD Scrase, D Azria, J Jansa, JM O'Sullivan, ACM Van Den Bergh, L Collette
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.